标准化^131Ⅰ治疗不同年龄段Grave’s甲亢的对比分析  

Comparative Analysis of Grave 's Hyperthyroidism Treated With Standardized ^(131)Ⅰ in Different Age Groups

作　　者：张力月[1] 

机构地区：[1]延边大学,延吉133000

出　　处：《中国继续医学教育》2016年第7期170-171,共2页China Continuing Medical Education

摘　　要：目的探讨标准化^(131)Ⅰ治疗不同年龄段Grave's甲亢的临床效果。方法根据年龄段不同,将99例Grave’s甲亢患者分成青年组(≤35岁)、中年组(36~59岁)、老年组(≥60岁)各33例,对比三组治疗结果。结果三组患者治愈率对比差异无统计学意义(P>0.05),老年组并发症发生率最高(P<0.05)。结论标准化131I治疗不同年龄段Grave’s甲亢的效果均肯定,中老年甲亢患者需注意控制并发症。Objective To investigate the standardization of different ages Grave＇s ^（131）Ⅰ treatment of hyperthyroidism clinical effect. Methods According to different age, The 99 cases of Graves＇ patients were divided into young group（ ≤ 35 years old）, middle age group（36 to 59 years old）, the elderly group（ ≥ 60 years old） all 33 cases, compared to three treatment outcome. Results The comparison of the three groups of patients cure rate was no significant difference（P〉0.05）, the highest incidence of complications in elderly group（P〈0.05）. Conclusion Standardization ^（131）Ⅰ treatment effect of different ages are sure Grave＇s hyperthyroidism, elderly patients with hyperthyroidism should pay attention to control complications.

关 键 词：标准化131Ⅰ 不同年龄段 Grave's甲亢 

分 类 号：R581[医药卫生—内分泌]